Healthcare provider profile · identity verified

Andrew Robert Eckert, DO

Internal Medicine · DILLSBURG, PA · NPI 1023218005

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	362	105
Lisinopril	Lisinopril	287	93
Amlodipine Besylate	Amlodipine Besylate	265	79
Losartan Potassium	Losartan Potassium	233	70
Rosuvastatin Calcium	Rosuvastatin Calcium	232	72
Levothyroxine Sodium	Levothyroxine Sodium	202	60
Simvastatin	Simvastatin	176	52
Pantoprazole Sodium	Pantoprazole Sodium	158	47
Omeprazole	Omeprazole	157	49
Gabapentin	Gabapentin	152	46
Metoprolol Succinate	Metoprolol Succinate	149	46
Jardiance	Empagliflozin	127	24
Furosemide	Furosemide	125	46
Metformin Hcl Er	Metformin Hcl	109	34
Hydrochlorothiazide	Hydrochlorothiazide	107	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	20
Tamsulosin Hcl	Tamsulosin Hcl	96	31
Metformin Hcl	Metformin Hcl	94	31
Trazodone Hcl	Trazodone Hcl	80	23
Allopurinol	Allopurinol	79	24
Sertraline Hcl	Sertraline Hcl	78	26
Metoprolol Tartrate	Metoprolol Tartrate	77	21
Eliquis	Apixaban	76	24
Lorazepam	Lorazepam	74	22
Tramadol Hcl	Tramadol Hcl	74	13
Citalopram Hbr	Citalopram Hydrobromide	72	19
Fluticasone Propionate	Fluticasone Propionate	69	22
Glimepiride	Glimepiride	66	19
Alendronate Sodium	Alendronate Sodium	60	18
Bupropion Xl	Bupropion Hcl	59	17
Clopidogrel	Clopidogrel Bisulfate	57	19
Zolpidem Tartrate	Zolpidem Tartrate	57	13
Pravastatin Sodium	Pravastatin Sodium	54	18
Clonazepam	Clonazepam	50	suppressed
Ondansetron Hcl	Ondansetron Hcl	50	11
Famotidine	Famotidine	49	17
Oxycodone Hcl	Oxycodone Hcl	49	13
Potassium Chloride	Potassium Chloride	49	19
Atenolol	Atenolol	48	16
Meloxicam	Meloxicam	48	16
Mounjaro	Tirzepatide	48	suppressed
Prednisone	Prednisone	48	27
Escitalopram Oxalate	Escitalopram Oxalate	47	16
Duloxetine Hcl	Duloxetine Hcl	46	12
Trulicity	Dulaglutide	46	suppressed
Montelukast Sodium	Montelukast Sodium	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Fenofibrate	Fenofibrate	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	15
Celecoxib	Celecoxib	36	suppressed
Ezetimibe	Ezetimibe	35	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Propranolol Hcl	Propranolol Hcl	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Diazepam	Diazepam	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	13
Hydralazine Hcl	Hydralazine Hcl	28	13
Albuterol Sulfate Hfa	Albuterol Sulfate	27	14
Doxycycline Hyclate	Doxycycline Hyclate	27	20
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	24	24
Finasteride	Finasteride	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Telmisartan	Telmisartan	23	suppressed
Nystatin	Nystatin	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	19
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Ozempic	Semaglutide	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Pregabalin	Pregabalin	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Azithromycin	Azithromycin	16	13
Fluconazole	Fluconazole	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Methylprednisolone	Methylprednisolone	14	13
Aptiom	Eslicarbazepine Acetate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quviviq	Daridorexant Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Digoxin	Digoxin	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error